Human herpesvirus-6 in hematopoietic stem cell transplant recipients: a prospective cohort study in Egypt.

Background: Immunocompromised patients face reactivation of latent viruses that increase the risk of morbidity.

Aim: The study aimed to detect human herpes virus 6 (HHV-6) reactivation among allogeneic (allo) and autologous (auto) hematopoietic stem cell transplant (HSCT) recipients and to correlate potentially attributed clinical manifestations to HHV-6 DNA plasma level.

Methods: A prospective study included all (forty) patients undergoing allo and auto-HSCT from Jan 2020 till June 2022.